Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Nature Genetics

• Publication date

  1996-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng1196-285PMID 8896557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat.

  1996cited by this paper
• Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo

  1996cited by this paper
• Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders.

  1996cited by this paper
• Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3.

  1996cited by this paper
• Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2

  1996cited by this paper
• Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): Genetic analysis of three unrelated SCA2 families

  1996cited by this paper
• Development of a screening set for new (CAG/CTG)n dynamic mutations.

  1996cited by this paper
• Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT

  1996cited by this paper
• Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular, and neuropathological features

  1996cited by this paper
• Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

  1996cited by this paper
• Trinucleotide repeats in neurogenetic disorders.

  1996cited by this paper
• Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease.

  1995cited by this paper
• Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

  1995cited by this paper
• Gametic and somatic tissue–specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1

  1995cited by this paper
• When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.

  1995cited by this paper
• Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2).

  1995cited by this paper
• Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

  1995cited by this paper
• Huntington's disease: CAG genetics expands neurobiology

  1995cited by this paper
• Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme

  1995cited by this paper
• A second-generation YAC contig map of human chromosome 12.

  1995cited by this paper
• Dentatorubral‐pallidoluysian atrophy: Clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat

  1995cited by this paper
• Characterization of four novel CAG repeat-containing cDNAs.

  1995cited by this paper
• Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.

  1995cited by this paper
• Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia.

  1995cited by this paper
• Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families.

  1995cited by this paper
• The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12–p21.1

  1995cited by this paper
• The spinocerebellar ataxia 2 locus is located within a 3-cM interval on chromosome 12q23-24.1.

  1995cited by this paper
• Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli

  1995cited by this paper
• Localization of the candidate gene D-amino acid oxidase outside the refined I-cM region of spinocerebellar ataxia 2.

  1995cited by this paper
• Localization of autosomal dominant cerebellar ataxia associated with retinal degeneration and anticipation to chromosome 3p12-p21.1.

  1995cited by this paper
• When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.

  1995cited by this paper
• Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families.

  1995cited by this paper
• Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset.

  1994cited by this paper
• The N‐terminal domain of the human TATA‐binding protein plays a role in transcription from TATA‐containing RNA polymerase II and III promoters.

  1994cited by this paper
• Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1linked to the SCA2 locus

  1994cited by this paper
• Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.

  1994cited by this paper
• Guidelines for the molecular genetics predictive test in Huntington's disease

  1994cited by this paper
• CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

  1994cited by this paper
• Genetic heterogeneity of dominantly inherited olivopontocerebellar atrophy (OPCA) in the Japanese: Linkage study of two pedigrees and evidence for the disease locus on chromosome 12q (SCA2)

  1994cited by this paper
• The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27.

  1994cited by this paper
• Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus.

  1994cited by this paper
• Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.

  1994cited by this paper
• Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.

  1994cited by this paper
• Length of uninterrupted CGG repeats determines instability in the FMR1 gene

  1994cited by this paper
• A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

  1994cited by this paper
• De novo expansion of a (CAG)n repeat in sporadic Huntington's disease

  1993cited by this paper
• Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23–24.1

  1993cited by this paper
• Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1

  1993cited by this paper
• Anticipation in spinocerebellar ataxia type 2

  1993cited by this paper
• Trinucleotide repeat length instability and age of onset in Huntington's disease

  1993cited by this paper
• Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I

  1993cited by this paper
• Genes with triplet repeats: candidate mediators of neuropsychiatric disorders.

  1993cited by this paper
• Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms.

  1993cited by this paper
• Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat

  1993cited by this paper
• Erratum: Human genes containing polymorphic trinucleotide repeats (Nature Genetics 2, 186-191 (1992))

  1993cited by this paper
• Association of fragile X syndrome with delayed replication of the FMR1 gene.

  1993cited by this paper
• Recoding: reprogrammed genetic decoding.

  1992cited by this paper
• Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy.

  1992cited by this paper
• Meiotic stability and genotype – phenotype correlation of the trinucleotide repeat in X–linked spinal and bulbar muscular atrophy

  1992cited by this paper
• Human genes containing polymorphic trinucleotide repeats

  1992cited by this paper
• Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.

  1991cited by this paper
• Autosomal dominant cerebellar ataxia

  1990cited by this paper
• An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

  1987cited by this paper
• The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'.

  1982cited by this paper

• Mitochondrial DNA Haplogroups and Age at Onset of Spinocerebellar Ataxia Type 2: A Study in Indian Patients.

  2026cites this paper
• Expanding the Genetic Landscape of ATXN2 Variants

  2026cites this paper
• Blood glucose homeostasis in patients with mild to moderate Spinocerebellar Ataxia type 2

  2026cites this paper
• Bioinformatic Analyses of the Ataxin-2 Family Since Algae Emphasize Its Small Isoforms, Large Chimerisms, and the Importance of Human Exon 1B as Target of Therapies to Prevent Neurodegeneration

  2026cites this paper
• The role of disease-associated short tandem repeats in amyotrophic lateral sclerosis

  2025cites this paper
• Multiomics approach identifies SERPINB1 as candidate biomarker for spinocerebellar ataxia type 2

  2025cites this paper
• Identifying Molecular Properties of Ataxin-2 Inhibitors for Spinocerebellar Ataxia Type 2 Utilizing High-Throughput Screening and Machine Learning

  2025cites this paper
• ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation

  2025cites this paper
• Spinal Cord Phosphoproteome of SCA2 Mouse Model Reveals Alteration of ATXN2-N-Term PRM–SH3–Actin Interactome and of Autophagy

  2025cites this paper
• Advances in ALS genetics and emerging precision therapies

  2025cites this paper
• Prioritising Functional Noncoding Variants via eRNA Post-transcriptional Interaction Maps in Human Samples

  2025cites this paper
• Progression of Gait Ataxia in Spinocerebellar Ataxia Type 2: Clinical Utility of Digitally Measured Gait Metrics

  2025cites this paper
• Staufen2 dysregulation in neurodegenerative disease

  2025cites this paper
• Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism

  2025cites this paper
• Conditional ATXN2L-Null in Adult Frontal Cortex CamK2a+ Neurons Does Not Cause Cell Death but Restricts Spontaneous Mobility and Affects the Alternative Splicing Pathway

  2025cites this paper
• Genomic Organization, Evolutionary Conservation and Expression of Ataxin-2 and Ataxin-2-like Genes Underscore the Suitability of Zebrafish as a Model Organism for SCA2 and Related Diseases

  2025cites this paper
• Spinocerebellar Ataxia Type 2

  2025cites this paper
• The Two Faces of Pediatric SCA2

  2025cites this paper
• Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43 ribonucleoprotein condensates disrupting mRNA transport and local translation in neurons.

  2024cites this paper
• Deciphering the interactome of Ataxin-2 and TDP-43 in iPSC-derived neurons for potential ALS targets

  2024cites this paper
• Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects

  2024cites this paper
• PolyQ-expanded ataxin-2 aggregation impairs cellular processing-body homeostasis via sequestering the RNA helicase DDX6

  2024cites this paper
• Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population

  2024cites this paper
• Ataxin‐2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling

  2024cites this paper
• Recent advances in the genetics of familial and sporadic ALS.

  2024cites this paper
• Cerebellar Micro-RNA Profile in a Mouse Model of Spinocerebellar Ataxia Type 2

  2024cites this paper
• Nucleus accumbens degeneration in spinocerebellar ataxia type 2: a preliminary study

  2024cites this paper
• The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease

  2024cites this paper
• Pbp1 associates with Puf3 and promotes translation of its target mRNAs involved in mitochondrial biogenesis

  2023cites this paper
• Poly(A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates.

  2023cites this paper
• Abnormal phase separation of biomacromolecules in human diseases

  2023cites this paper
• Genetic variation associated with human longevity and Alzheimer's disease risk act through microglia and oligodendrocyte cross-talk

  2023cites this paper
• Spinocerebellar Ataxia Type 2: A Family Re-port

  2023cites this paper
• Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43, drive ribonucleoprotein condensate transport dysfunction and suppress local translation

  2023cites this paper
• Neurogenetic motor disorders.

  2023cites this paper
• TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2

  2023cites this paper
• A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases

  2022cites this paper
• Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2

  2022cites this paper
• Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2

  2022cites this paper
• Cognition in Trinucleotide Repeat Spinocerebellar Ataxias: A Review

  2022cites this paper
• Hsc70-4 aggravates PolyQ-mediated neurodegeneration by modulating NF-κB mediated immune response in Drosophila

  2022cites this paper
• The Clinical and Polynucleotide Repeat Expansion Analysis of ATXN2, NOP56, AR and C9orf72 in Patients With ALS From Mainland China

  2022cites this paper
• ATXN2 is a target of N-terminal proteolysis

  2022cites this paper
• Expression profile analysis in cells overexpressing DRPLA cDNA to explore the roles of DRPLAp as a transcriptional coregulator

  2022cites this paper
• Are ATXN2 variants modifying our understanding about neural pathogenesis, phenotypes, and diagnostic?

  2022influential citation
• Molecular Mechanisms in Pentanucleotide Repeat Diseases

  2022cites this paper
• Parallel Appearance of Polyglutamine and Transactivation-Responsive DNA-Binding Protein 43 and Their Complementary Subcellular Localization in Brains of Patients With Spinocerebellar Ataxia Type 2.

  2022cites this paper
• Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders

  2022cites this paper
• A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2

  2022cites this paper
• The RNA‐binding protein and stress granule component ATAXIN‐2 is expressed in mouse and human tissues associated with glaucoma pathogenesis

  2021cites this paper
• Anticipation Can Be More Common in Hereditary Spastic Paraplegia with SPAST Mutations Than It Appears

  2021cites this paper
• Poly(A)-binding protein is an ataxin-2 chaperone that emulsifies biomolecular condensates

  2021cites this paper
• mGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease.

  2021cites this paper
• Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale

  2021cites this paper
• RNA Dynamics in Alzheimer’s Disease

  2021cites this paper
• Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2

  2021cites this paper
• Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1

  2021cites this paper
• The Disease-Associated Proteins Drosophila Nab2 and Ataxin-2 Interact with Shared RNAs and Coregulate Neuronal Morphology

  2021cites this paper
• Spinocerebellar ataxia type 2 from an evolutionary perspective: Systematic review and meta‐analysis

  2021cites this paper
• Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences

  2021cites this paper
• Small molecule v-ATPase inhibitor Etidronate lowers levels of ALS protein ataxin-2

  2021cites this paper
• Ataxin-2 gene: a powerful modulator of neurological disorders

  2021cites this paper
• The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington’s Disease: A Historical Perspective

  2021cites this paper
• Combating deleterious phase transitions in neurodegenerative disease.

  2021cites this paper
• Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients

  2021cites this paper
• RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective

  2021cites this paper
• The ATXN2 Orthologs CID3 and CID4, Act Redundantly to In-Fluence Developmental Pathways throughout the Life Cycle of Arabidopsis thaliana

  2021cites this paper
• Gene therapy for ALS: A review

  2021cites this paper
• Repeat RNA Toxicity Drives Ribosomal RNA Processing Defects in SCA2

  2021cites this paper
• Identification of GOLPH3 Partners in Drosophila Unveils Potential Novel Roles in Tumorigenesis and Neural Disorders

  2021cites this paper
• Neuropathology of Ataxias

  2021cites this paper
• What is the Pathogenic CAG Expansion Length in Huntington’s Disease?

  2021cites this paper
• Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence

  2021cites this paper
• CCG•CGG interruptions in high‐penetrance SCA8 families increase RAN translation and protein toxicity

  2021cites this paper
• A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72‐ALS

  2020cites this paper
• Genetic profile and clinical characteristics of Chinese patients with spinocerebellar ataxia type 2: A multicenter experience over 10 years

  2020cites this paper
• Mouse Ataxin-2 Expansion Downregulates CamKII

  2020cites this paper
• Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits

  2020cites this paper
• Direct evidence that Ataxin-2 is a translational activator mediating cytoplasmic polyadenylation

  2020cites this paper
• Pathogenic mechanisms underlying spinocerebellar ataxia type 1

  2020cites this paper
• Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion

  2020cites this paper
• Therapeutic antisense oligonucleotides for movement disorders

  2020cites this paper
• On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability

  2020influential citation
• Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.

  2020cites this paper
• The RNA-Binding Protein ATXN2 is Expressed during Megakaryopoiesis and May Control Timing of Gene Expression

  2020cites this paper
• Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias

  2020cites this paper
• Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells

  2020cites this paper
• Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders

  2020cites this paper
• supplemental information

  2020cites this paper
• Intricacies of aetiology in intrafamilial degenerative disease

  2020cites this paper
• Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions

  2020cites this paper
• Dentatorubral-pallidoluysian atrophy (DRPLA).

  2020cites this paper
• Mouse Ataxin-2 Expansion Downregulates CamKII and Other Calcium Signaling Factors, Impairing Granule—Purkinje Neuron Synaptic Strength

  2020cites this paper
• Transcribed microsatellite allele lengths are often correlated with gene expression in natural sunflower populations

  2020cites this paper
• Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations

  2019cites this paper
• Insights into cognitive decline in spinocerebellar Ataxia type 2: a P300 event-related brain potential study

  2019cites this paper
• Motor Performances of Spontaneous and Genetically Modified Mutants with Cerebellar Atrophy

  2019cites this paper
• Genetics of amyotrophic lateral sclerosis: A review.

  2019cites this paper
• Notch Signaling: From Neurogenesis to Neurodegeneration

  2019cites this paper
• New pathologic mechanisms in nucleotide repeat expansion disorders.

  2019cites this paper